Literature DB >> 29067708

Preliminary study of the application of transthoracic echocardiography-guided three-dimensional printing for the assessment of structural heart disease.

Yanbo Zhu1,2, Jianshi Liu3, Lianqun Wang3, Xin Guan2, Yongjuan Luo2, Jie Geng4, Qingguo Geng2, Yunjia Lin2, Lixia Zhang2, Xixue Li2, Yaping Lu2.   

Abstract

OBJECTIVE: To investigate the feasibility and diagnostic value of a preoperative transthoracic echocardiography-guided three-dimensional printed model (TTE-guided 3DPM) for the assessment of structural heart disease (SHD).
METHODS: Fourty-four patients underwent cardiac surgery at Tianjin Chest Hospital. The patients were preoperatively assessed using TTE-guided 3DPM, which was compared to conventional three-dimensional transthoracic echocardiography (3DTTE) along with direct intraoperative findings, which were considered the "gold standard." Twelve patients had SHD, including four with mitral prolapse, two with partial endocardial cushion defects, two with secondary atrial septal defects, two with rheumatic mitral stenosis, one with tetralogy of Fallot, and one with a ventricular septal defect (VSD). Thirty-two patients who did not have SHDs were designated as the negative control group.
RESULTS: The sensitivity and specificity of the TTE-guided 3DPM were greater than or equal to those of the 3DTTE. The P-value of the McNemar test of 3DTTE was >.05, which indicates that the difference was not statistically significant (Kappa = 0.745, P < .001). The P-value of the McNemar test of TTE-guided 3DPM was >.05, which indicates that the difference was not statistically significant (Kappa = 0.955, P < .001). A comparison of 3DTTE and TTE-guided 3DPM resulted in a P-value >.05, which indicates that the difference was not statistically significant (Kappa = 0.879, P < .001). TTE-guided 3DPM displayed the 3D structure of SHDs and cardiac lesions clearly and was consistent with the intra-operative findings.
CONCLUSION: Transthoracic echocardiography-guided three-dimensional printed model (TTE-guided 3DPM) provides essential information for preoperative evaluation and decision making for patients with SHDs.
© 2017, Wiley Periodicals, Inc.

Entities:  

Keywords:  echocardiography; structural heart disease; three-dimensional; three-dimensional printing

Mesh:

Year:  2017        PMID: 29067708     DOI: 10.1111/echo.13715

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  2 in total

1.  Hemodynamic testing using three-dimensional printing and computational fluid dynamics preoperatively may provide more information in mitral repair than traditional image dataset.

Authors:  Hao Wang; Hongning Song; Yuanting Yang; Zhiyong Wu; Rui Hu; Jinling Chen; Juan Guo; Yijia Wang; Dan Jia; Sheng Cao; Qing Zhou; Ruiqiang Guo
Journal:  Ann Transl Med       Date:  2021-04

Review 2.  Three-dimensional printing for cardiovascular diseases: from anatomical modeling to dynamic functionality.

Authors:  Hao Wang; Hongning Song; Yuanting Yang; Quan Cao; Yugang Hu; Jinling Chen; Juan Guo; Yijia Wang; Dan Jia; Sheng Cao; Qing Zhou
Journal:  Biomed Eng Online       Date:  2020-10-07       Impact factor: 2.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.